Inhibikase Therapeutics Inc (IKT)

Other Income/Expenses (Net)

$5.17M

TTM · Period ending: · USD

IKT logo

IKT Other Income/Expenses (Net)

Latest reported$5.17M
IKT TTM Other Income/Expenses (Net) (-$33.18K → $5.17M)
High-resolution chart · PNG

IKT other income/expenses (net) history

Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.

Inhibikase Therapeutics Inc Other Income/Expenses (Net) — Trailing twelve months (TTM) (USD)
Period endingOther Income/Expenses (Net) (USD)
5,173,265
4,630,256
3,715,094
3,470,242
2,681,559
1,855,731
1,069,185
498,687
622,954
956,462
1,060,908
891,205
736,064
311,629
74,453
18,373
-320
-8,131
-19,923
-26,904
-33,637
-33,774
-29,402
-30,010
-30,932
-28,590
-24,835
-22,715
-26,818
-30,492
-33,176
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.